Symbols / NXGL Stock $0.54 -4.24% NEXGEL, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
NXGL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Adam R. Levy
Exch · Country NCM · United States
Market Cap 4.94M
Enterprise Value 9.67M
Income -3.21M
Sales 11.27M
FCF (ttm) -2.09M
Book/sh 0.47
Cash/sh 0.02
Employees 19
Insider 10d —
IPO Dec 22, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 1.34
PEG —
P/S 0.44
P/B 1.14
P/C —
EV/EBITDA -3.12
EV/Sales 0.86
Quick Ratio 0.26
Current Ratio 1.70
Debt/Eq 95.63
LT Debt/Eq —
EPS (ttm) -0.40
EPS next Y 0.40
EPS Growth —
Revenue Growth -5.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-11
Earnings (prior) 2026-05-14
ROA -20.04%
ROE -61.41%
ROIC —
Gross Margin 38.90%
Oper. Margin -36.15%
Profit Margin -28.54%
Shs Outstand 9.23M
Shs Float 7.01M
Insider Own 14.76%
Instit Own 13.57%
Short Float 1.38%
Short Ratio 0.76
Short Interest 106.69K
52W High 2.89
vs 52W High -81.49%
52W Low 0.48
vs 52W Low 11.23%
Beta —
Impl. Vol. —
Rel Volume 1.29
Avg Volume 300.07K
Volume 386.68K
Target (mean) $2.00
Tgt Median $2.00
Tgt Low $2.00
Tgt High $2.00
# Analysts 1
Recom None
Prev Close $0.56
Price $0.54
Change -4.24%
About

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.00
Mean price target
2. Current target
$0.54
Latest analyst target
3. DCF / Fair value
$-4.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.54
Low
$2.00
High
$2.00
Mean
$2.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-12 main Maxim Group Buy → Buy $2
2022-02-25 init Maxim Group — → Buy $6
News
RSS: Latest NXGL news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-23 LEVY ADAM R Chief Executive Officer — 11,000 $0.59 $6,519
2026-06-11 LEVY ADAM R Chief Executive Officer — 3,000 $0.61 $1,841
2026-06-08 LEVY ADAM R Chief Executive Officer — 6,000 $0.55 $3,422
2026-06-01 LEVY ADAM R Chief Executive Officer — 2,000 $0.59 $1,172
2026-05-29 LEVY ADAM R Chief Executive Officer — 13,000 $0.60 $7,834
2025-12-24 LEVY ADAM R Chief Executive Officer — 10,000 $1.57 $15,947
2025-11-06 LEVY ADAM R Chief Executive Officer — 4,000 $2.52 $10,084
2025-10-03 LEVY ADAM R Chief Executive Officer — 4,000 $2.50 $10,119
2025-10-03 HENRY SCOTT ROBERT Director — 8,000 $2.50 $20,360
2025-09-25 HENRY SCOTT ROBERT Director — 7,697 $2.36 $18,149
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
11.42
+31.46%
8.69
+112.47%
4.09
+99.66%
2.05
Operating Revenue
11.00
+31.53%
8.37
+108.89%
4.00
+112.81%
1.88
Cost Of Revenue
6.91
+16.36%
5.94
+59.89%
3.71
+107.31%
1.79
Reconciled Cost Of Revenue
6.91
+16.36%
5.94
+74.81%
3.40
+125.48%
1.51
Gross Profit
4.51
+64.08%
2.75
+634.76%
0.37
+46.09%
0.26
Operating Expense
7.86
+24.74%
6.30
+63.65%
3.85
+6.85%
3.60
Research And Development
0.00
-97.44%
0.08
-24.27%
0.10
-71.93%
0.37
Selling General And Administration
7.86
+26.27%
6.22
+83.17%
3.40
+20.67%
2.82
Selling And Marketing Expense
—
2.22
+404.55%
0.44
+0.92%
0.44
General And Administrative Expense
—
3.69
+24.78%
2.96
+24.29%
2.38
Salaries And Wages
—
1.36
+43.90%
0.94
+16.71%
0.81
Other Gand A
—
2.33
+15.83%
2.02
+28.18%
1.57
Total Expenses
14.77
+20.67%
12.24
+61.80%
7.57
+40.21%
5.40
Operating Income
-3.35
+5.68%
-3.55
-2.21%
-3.48
-3.85%
-3.35
Total Operating Income As Reported
-3.35
+5.68%
-3.55
-2.21%
-3.48
-3.85%
-3.35
EBITDA
-2.12
+22.01%
-2.72
+0.48%
-2.73
+12.19%
-3.11
Normalized EBITDA
-2.40
+14.17%
-2.79
+7.36%
-3.02
+0.89%
-3.04
Reconciled Depreciation
0.74
+11.28%
0.67
+50.11%
0.44
+47.18%
0.30
EBIT
-2.86
+15.46%
-3.38
-6.59%
-3.17
+6.95%
-3.41
Total Unusual Items
0.28
+258.97%
0.08
-72.82%
0.29
+541.54%
-0.07
Total Unusual Items Excluding Goodwill
0.28
+258.97%
0.08
-72.82%
0.29
+541.54%
-0.07
Special Income Charges
0.16
+1000.00%
-0.02
0.00
+100.00%
-0.15
Other Special Charges
—
—
—
0.15
Restructuring And Mergern Acquisition
0.00
-100.00%
0.02
0.00
—
Net Income
-3.00
+8.56%
-3.28
-3.93%
-3.16
+33.48%
-4.75
Pretax Income
-2.89
+16.46%
-3.46
-8.63%
-3.19
+32.83%
-4.75
Net Non Operating Interest Income Expense
-0.03
+58.02%
-0.08
-440.00%
-0.01
+98.88%
-1.34
Interest Expense Non Operating
0.03
-58.02%
0.08
+440.00%
0.01
-98.88%
1.34
Net Interest Income
-0.03
+58.02%
-0.08
-440.00%
-0.01
+98.88%
-1.34
Interest Expense
0.03
-58.02%
0.08
+440.00%
0.01
-98.88%
1.34
Other Income Expense
0.49
+186.63%
0.17
-43.42%
0.30
+590.32%
-0.06
Other Non Operating Income Expenses
0.21
+126.60%
0.09
+452.94%
0.02
+466.67%
0.00
Gain On Sale Of Security
0.12
+22.92%
0.10
-66.55%
0.29
+237.65%
0.09
Gain On Sale Of Business
0.16
0.00
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-2.89
+16.46%
-3.46
-8.63%
-3.19
+32.83%
-4.75
Net Income From Continuing Operation Net Minority Interest
-3.00
+8.56%
-3.28
-3.93%
-3.16
+33.48%
-4.75
Net Income From Continuing And Discontinued Operation
-3.00
+8.56%
-3.28
-3.93%
-3.16
+33.48%
-4.75
Net Income Continuous Operations
-2.89
+16.46%
-3.46
-8.63%
-3.19
+32.83%
-4.75
Minority Interests
-0.11
-158.79%
0.18
+487.10%
0.03
0.00
Normalized Income
-3.28
+2.35%
-3.36
+2.47%
-3.44
+26.43%
-4.68
Net Income Common Stockholders
-3.00
+8.56%
-3.28
-3.93%
-3.16
+33.48%
-4.75
Diluted EPS
-0.38
+24.00%
-0.50
+10.71%
-0.56
+34.12%
-0.85
Basic EPS
-0.38
+24.00%
-0.50
+10.71%
-0.56
+34.12%
-0.85
Basic Average Shares
7.85
+20.62%
6.51
+14.81%
5.67
+1.74%
5.57
Diluted Average Shares
7.85
+20.62%
6.51
+14.81%
5.67
+1.74%
5.57
Diluted NI Availto Com Stockholders
-3.00
+8.56%
-3.28
-3.93%
-3.16
+33.48%
-4.75
Depreciation Amortization Depletion Income Statement
—
0.16
+23.81%
0.13
+687.50%
0.02
Depreciation And Amortization In Income Statement
—
0.16
+23.81%
0.13
+687.50%
0.02
Other Taxes
—
0.16
-29.91%
0.22
-44.69%
0.41
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
10.46
-4.75%
10.98
+10.33%
9.96
-3.88%
10.36
Current Assets
4.34
-15.17%
5.11
+1.23%
5.05
-32.68%
7.50
Cash Cash Equivalents And Short Term Investments
0.32
-82.46%
1.81
-33.07%
2.70
-59.15%
6.61
Cash And Cash Equivalents
0.32
-82.46%
1.81
-33.07%
2.70
+145.23%
1.10
Cash Financial
0.32
-82.46%
1.81
-33.07%
2.70
+145.23%
1.10
Other Short Term Investments
—
—
0.00
-100.00%
5.51
Receivables
0.67
-27.87%
0.93
+47.39%
0.63
+185.14%
0.22
Accounts Receivable
0.67
-27.87%
0.93
+47.39%
0.63
+185.14%
0.22
Gross Accounts Receivable
0.68
-27.29%
0.94
+45.65%
0.64
+178.79%
0.23
Allowance For Doubtful Accounts Receivable
-0.01
-80.00%
-0.01
+54.55%
-0.01
-22.22%
-0.01
Inventory
2.11
+20.56%
1.75
+32.75%
1.32
+162.75%
0.50
Raw Materials
1.37
+78.67%
0.77
-14.46%
0.90
+204.75%
0.29
Work In Process
0.05
+88.00%
0.03
+108.33%
0.01
-76.47%
0.05
Finished Goods
0.96
-4.19%
1.00
+145.83%
0.41
+161.54%
0.16
Prepaid Assets
0.04
-2.17%
0.05
-28.13%
0.06
+1.59%
0.06
Restricted Cash
0.74
0.00
—
—
Other Current Assets
0.45
-21.84%
0.58
+71.73%
0.34
+208.26%
0.11
Total Non Current Assets
6.12
+4.33%
5.87
+19.70%
4.90
+71.91%
2.85
Net PPE
3.97
+3.41%
3.84
+14.46%
3.35
+36.45%
2.46
Gross PPE
5.34
+9.32%
4.88
+19.71%
4.08
+33.68%
3.05
Accumulated Depreciation
-1.37
-31.00%
-1.04
-43.94%
-0.73
-22.22%
-0.59
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
2.36
+2.30%
2.31
+62.44%
1.42
+37.50%
1.03
Construction In Progress
0.55
+2.82%
0.53
+37.47%
0.39
+603.64%
0.06
Other Properties
2.02
+23.77%
1.63
-12.24%
1.85
+6.79%
1.74
Leases
0.42
+0.00%
0.42
+0.00%
0.42
+83.77%
0.23
Goodwill And Other Intangible Assets
1.81
-6.51%
1.94
+33.08%
1.45
+339.27%
0.33
Goodwill
1.13
+0.00%
1.13
+0.00%
1.13
+262.70%
0.31
Other Intangible Assets
0.68
-15.61%
0.81
+147.55%
0.33
+1530.00%
0.02
Investments And Advances
0.25
0.00
—
—
Long Term Equity Investment
0.25
0.00
—
—
Other Non Current Assets
0.10
+0.00%
0.10
+0.00%
0.10
+50.79%
0.06
Total Liabilities Net Minority Interest
5.57
+13.60%
4.90
+2.38%
4.79
+76.07%
2.72
Current Liabilities
2.96
+19.68%
2.47
-3.10%
2.55
+196.74%
0.86
Payables And Accrued Expenses
1.42
-7.76%
1.53
+18.55%
1.29
+246.92%
0.37
Payables
1.29
-0.23%
1.29
+4.79%
1.23
+288.96%
0.32
Accounts Payable
1.29
-0.23%
1.29
+4.79%
1.23
+365.28%
0.27
Current Accrued Expenses
0.13
-47.93%
0.24
+296.72%
0.06
+8.93%
0.06
Total Tax Payable
—
—
0.00
-100.00%
0.05
Current Debt And Capital Lease Obligation
0.47
+20.61%
0.39
-29.57%
0.56
+151.35%
0.22
Current Debt
0.10
+2.06%
0.10
-70.15%
0.33
+2066.67%
0.01
Other Current Borrowings
0.10
+2.06%
0.10
+21.25%
0.08
+433.33%
0.01
Current Capital Lease Obligation
0.38
+26.69%
0.30
+27.04%
0.23
+12.56%
0.21
Current Deferred Liabilities
0.73
+309.50%
0.18
+795.00%
0.02
0.00
Current Deferred Revenue
0.00
-98.88%
0.18
+795.00%
0.02
0.00
Other Current Liabilities
0.33
-8.24%
0.36
-46.23%
0.68
+156.44%
0.26
Total Non Current Liabilities Net Minority Interest
2.61
+7.44%
2.43
+8.62%
2.24
+20.37%
1.86
Long Term Debt And Capital Lease Obligation
2.61
+7.44%
2.43
+8.62%
2.24
+20.37%
1.86
Long Term Debt
0.49
-16.84%
0.59
+14.62%
0.51
+91.42%
0.27
Long Term Capital Lease Obligation
2.12
+15.18%
1.84
+6.83%
1.73
+8.41%
1.59
Stockholders Equity
4.46
-22.52%
5.75
+22.53%
4.70
-38.50%
7.64
Common Stock Equity
4.46
-22.52%
5.75
+22.53%
4.70
-38.50%
7.64
Capital Stock
0.01
+0.00%
0.01
+33.33%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+33.33%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
8.14
+6.61%
7.64
+33.03%
5.74
+2.94%
5.58
Ordinary Shares Number
8.14
+6.61%
7.64
+33.03%
5.74
+2.94%
5.58
Additional Paid In Capital
25.45
+7.18%
23.74
+22.35%
19.41
+1.13%
19.19
Retained Earnings
-21.00
-16.67%
-18.00
-22.30%
-14.71
-27.31%
-11.56
Minority Interest
0.43
+32.92%
0.33
-30.70%
0.47
0.00
Total Equity Gross Minority Interest
4.89
-19.56%
6.08
+17.69%
5.17
-32.36%
7.64
Total Capitalization
4.95
-21.99%
6.34
+21.75%
5.21
-34.09%
7.91
Working Capital
1.38
-47.73%
2.64
+5.63%
2.50
-62.34%
6.65
Invested Capital
5.05
-21.63%
6.44
+16.35%
5.54
-30.11%
7.92
Total Debt
3.09
+9.27%
2.83
+1.00%
2.80
+34.33%
2.08
Net Debt
0.27
—
—
—
Capital Lease Obligations
2.50
+16.77%
2.14
+9.23%
1.96
+8.89%
1.80
Net Tangible Assets
2.65
-30.63%
3.82
+17.79%
3.24
-55.61%
7.31
Tangible Book Value
2.65
-30.63%
3.82
+17.79%
3.24
-55.61%
7.31
Current Notes Payable
—
—
—
—
Dueto Related Parties Current
—
0.53
-18.81%
0.65
—
Inventories Adjustments Allowances
-0.27
-489.13%
-0.05
0.00
0.00
Investments In Other Ventures Under Equity Method
0.25
0.00
—
—
Line Of Credit
—
0.00
-100.00%
0.24
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-1.31
+66.10%
-3.87
-19.50%
-3.24
-8.16%
-2.99
Cash Flow From Continuing Operating Activities
-1.31
+66.08%
-3.87
-19.44%
-3.24
-8.16%
-2.99
Net Income From Continuing Operations
-2.89
+16.46%
-3.46
-9.69%
-3.16
+33.48%
-4.75
Depreciation Amortization Depletion
0.74
+11.28%
0.67
+50.11%
0.44
+47.18%
0.30
Depreciation
0.61
+12.45%
0.55
+56.45%
0.35
+21.18%
0.29
Amortization Cash Flow
0.13
+5.88%
0.12
+26.60%
0.09
+623.08%
0.01
Depreciation And Amortization
0.74
+11.28%
0.67
+50.11%
0.44
+47.18%
0.30
Amortization Of Intangibles
0.13
+5.88%
0.12
+26.60%
0.09
+623.08%
0.01
Other Non Cash Items
—
0.02
+151.61%
-0.03
-102.34%
1.32
Stock Based Compensation
0.65
+78.20%
0.37
+69.12%
0.22
-27.18%
0.30
Operating Gains Losses
-0.28
-191.67%
-0.10
+66.55%
-0.29
-541.54%
0.07
Gain Loss On Investment Securities
-0.12
-22.92%
-0.10
+66.55%
-0.29
-237.65%
-0.09
Change In Working Capital
0.47
+134.51%
-1.36
-222.09%
-0.42
-79.91%
-0.23
Change In Receivables
0.26
+186.67%
-0.30
+27.01%
-0.41
-3061.54%
-0.01
Changes In Account Receivables
0.26
+186.67%
-0.30
+27.01%
-0.41
-3061.54%
-0.01
Change In Inventory
-0.36
+16.67%
-0.43
+43.16%
-0.76
-260.19%
-0.21
Change In Prepaid Assets
0.86
+484.75%
-0.22
+14.23%
-0.26
-173.68%
-0.10
Change In Payables And Accrued Expense
0.15
+139.20%
-0.38
-137.88%
0.99
+1064.71%
0.09
Change In Accrued Expense
0.15
+134.56%
-0.43
-2072.73%
0.02
-70.27%
0.07
Change In Payable
-0.00
-105.08%
0.06
-93.90%
0.97
+8700.00%
0.01
Change In Account Payable
-0.00
-105.08%
0.06
-93.90%
0.97
+8700.00%
0.01
Change In Other Working Capital
-0.18
-211.32%
0.16
+695.00%
0.02
—
Change In Other Current Liabilities
-0.26
-40.54%
-0.18
—
—
Investing Cash Flow
-0.07
+91.23%
-0.78
-117.39%
4.46
+179.64%
-5.59
Cash Flow From Continuing Investing Activities
-0.07
+91.23%
-0.78
-117.39%
4.46
+179.64%
-5.59
Net PPE Purchase And Sale
-0.07
+84.65%
-0.44
+36.35%
-0.70
-625.00%
-0.10
Purchase Of PPE
-0.07
+84.65%
-0.44
+36.35%
-0.70
-625.00%
-0.10
Capital Expenditure
-0.07
+84.65%
-0.44
+36.35%
-0.70
-625.00%
-0.10
Net Investment Purchase And Sale
0.00
-100.00%
0.07
-98.81%
5.70
+203.64%
-5.50
Purchase Of Investment
—
—
0.00
+100.00%
-7.00
Sale Of Investment
0.00
-100.00%
0.07
-98.81%
5.70
+279.93%
1.50
Net Business Purchase And Sale
0.00
+100.00%
-0.40
+26.87%
-0.55
0.00
Purchase Of Business
0.00
+100.00%
-0.40
+26.87%
-0.55
0.00
Gain Loss On Sale Of Business
-0.16
0.00
—
—
Financing Cash Flow
0.63
-83.20%
3.75
+889.18%
0.38
+110.35%
-3.66
Cash Flow From Continuing Financing Activities
0.63
-83.20%
3.75
+889.18%
0.38
+110.35%
-3.66
Net Issuance Payments Of Debt
-0.16
-171.56%
0.22
-42.48%
0.38
+110.35%
-3.66
Issuance Of Debt
0.00
-100.00%
0.34
-38.39%
0.56
0.00
Repayment Of Debt
-0.16
-22.83%
-0.13
+29.83%
-0.18
+95.06%
-3.66
Long Term Debt Issuance
—
0.00
-100.00%
0.32
0.00
Long Term Debt Payments
-0.16
-22.83%
-0.13
+29.83%
-0.18
-19.87%
-0.15
Net Long Term Debt Issuance
-0.16
-22.83%
-0.13
-194.78%
0.13
+188.74%
-0.15
Short Term Debt Issuance
0.00
-100.00%
0.34
+40.82%
0.24
0.00
Short Term Debt Payments
—
—
0.00
+100.00%
-3.51
Net Short Term Debt Issuance
0.00
-100.00%
0.34
+40.82%
0.24
+106.98%
-3.51
Net Common Stock Issuance
0.96
-74.47%
3.77
0.00
0.00
Net Other Financing Charges
-0.18
+26.56%
-0.24
—
—
Changes In Cash
-0.75
+16.13%
-0.89
-155.85%
1.60
+113.05%
-12.25
Beginning Cash Position
1.81
-33.07%
2.70
+145.23%
1.10
-91.75%
13.35
End Cash Position
1.06
-41.45%
1.81
-33.07%
2.70
+145.23%
1.10
Free Cash Flow
-1.38
+68.00%
-4.31
-9.61%
-3.93
-27.33%
-3.09
Common Stock Issuance
0.96
-74.47%
3.77
0.00
0.00
Issuance Of Capital Stock
0.96
-74.47%
3.77
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category